Brownlie Keith L
Insider CIK 1518575 · EPCT Director · CGIX Director · RXII Director · CLDX Director · SNGX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2026-06-25 | 2026-06-29 | 26,000 | — | $0 | 26,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 16,500 | — | $0 | 16,500 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-17 | 16,500 | — | $0 | 16,500 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 11,300 | — | $0 | 11,300 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 13,600 | — | $0 | 13,600 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 11,000 | — | $0 | 11,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2019-06-19 | 2019-06-20 | 4,500 | — | $0 | 4,500 | SEC↗ |
| PHIO Phio Pharmaceuticals Corp. | A Award | 2019-02-13 | 2019-02-15 | 10,000 | — | $0 | 20,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2018-09-27 | 2018-09-28 | 17,964 | — | $0 | 17,964 | SEC↗ |
| RXII RXi Pharmaceuticals Corp | A Award | 2018-08-01 | 2018-08-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2018-06-13 | 2018-06-15 | 67,000 | — | $0 | 67,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2017-06-15 | 2017-06-16 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2017-06-15 | 2017-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award | 2017-06-15 | 2017-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2017-06-08 | 2017-06-12 | 13,100 | — | $0 | 13,100 | SEC↗ |
| RXII RXi Pharmaceuticals Corp | A Award deriv | 2017-02-01 | 2017-02-03 | 2,000 | — | $0 | 2,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2016-06-16 | 2016-06-20 | 40,541 | — | $0 | 40,541 | SEC↗ |
| RXII RXi Pharmaceuticals Corp | A Award deriv | 2016-02-10 | 2016-02-12 | 16,666 | — | $0 | 16,666 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2015-06-18 | 2015-06-19 | 19,868 | — | $0 | 19,868 | SEC↗ |
| RXII RXi Pharmaceuticals Corp | A Award deriv | 2015-06-01 | 2015-06-02 | 16,666 | — | $0 | 16,666 | SEC↗ |
| SNGX SOLIGENIX, INC. | M Exercise deriv | 2015-04-09 | 2015-04-09 | 14,286 | — | $0 | 0 | SEC↗ |
| SNGX SOLIGENIX, INC. | M Exercise | 2015-04-09 | 2015-04-09 | 14,286 | $0.61 | $8.7K | 50,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2014-06-19 | 2014-06-20 | 13,669 | — | $0 | 13,669 | SEC↗ |
| RXII RXi Pharmaceuticals Corp | A Award deriv | 2014-06-02 | 2014-06-04 | 16,666 | — | $0 | 16,666 | SEC↗ |
| CGIX CANCER GENETICS, INC | A Award deriv | 2014-05-22 | 2014-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CGIX CANCER GENETICS, INC | A Award | 2014-05-22 | 2014-05-27 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | M Exercise deriv | 2014-05-14 | 2014-05-16 | 16,667 | — | $0 | 8,333 | SEC↗ |
| SNGX SOLIGENIX, INC. | M Exercise | 2014-05-14 | 2014-05-16 | 16,667 | $0.30 | $5.0K | 35,714 | SEC↗ |
| CGIX CANCER GENETICS, INC | A Award deriv | 2013-10-10 | 2013-10-15 | 12,312 | — | $0 | 12,312 | SEC↗ |
| CGIX CANCER GENETICS, INC | A Award deriv | 2013-10-10 | 2013-10-15 | 10,000 | — | $0 | 22,312 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2013-09-27 | 2013-10-01 | 13,275 | — | $0 | 13,275 | SEC↗ |
| EPCT EPICEPT CORP | A Award | 2013-08-12 | 2013-08-14 | 300,000 | — | $0 | 360,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | P Buy deriv | 2013-06-25 | 2013-06-26 | 14,286 | — | $0 | 14,285 | SEC↗ |
| SNGX SOLIGENIX, INC. | P Buy | 2013-06-25 | 2013-06-26 | 19,047 | $1.05 | $20.0K | 19,047 | SEC↗ |
| RXII RXi Pharmaceuticals Corp | A Award deriv | 2013-06-07 | 2013-06-11 | 500,000 | — | $0 | 500,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2012-06-21 | 2012-07-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EPCT EPICEPT CORP | A Award deriv | 2012-06-21 | 2012-06-25 | 60,000 | — | $0 | 60,000 | SEC↗ |